NCT05496504 is a clinical trial of Holter ECG in Pulmonary Hypertension, sponsored by Asklepios Neurological Clinic Bad Salzhausen.

Who is sponsoring NCT05496504?

NCT05496504 is sponsored by Asklepios Neurological Clinic Bad Salzhausen.

What drugs are being tested in NCT05496504?

Interventions in NCT05496504: Holter ECG.

What condition does NCT05496504 study?

NCT05496504 studies Pulmonary Hypertension.

Is NCT05496504 still recruiting?

NCT05496504 is currently completed. Last updated 13 June 2023.

Last reviewed 2023-06-13 · How we verify

NCT05496504

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulmonary Hypertension and Arrhythmia

Completed Last updated 13 June 2023

What this trial tests

trial testing Holter ECG in Pulmonary Hypertension in 222 participants. Completed in 31 December 2015.

Timeline

1 September 2013

Primary endpoint
31 December 2015

31 December 2015

Quick facts

Lead sponsor	Asklepios Neurological Clinic Bad Salzhausen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	222
Start date	1 September 2013
Primary completion	31 December 2015
Estimated completion	31 December 2015

Drugs / interventions tested

Holter ECG

Conditions studied

Pulmonary Hypertension — all drugs for Pulmonary Hypertension →

Sponsor

Asklepios Neurological Clinic Bad Salzhausen

Who can join

18 and older, any sex, with Pulmonary Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with pulmonary hypertension underwent (routine) Holter ECG and were screened for (malignant) arrhyhtmias. Results of Holter ECGs were correlated with clinicial and technical data (echocardiography and right heart catheterization).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Incidence and prognostic significance of malignant arrhythmias during (repetitive) Holter electrocardiograms in patients with pulmonary hypertension.
Bandorski D, Heibel S, Höltgen R, Bogossian H, et al · · 2023 · cited 2× · PMID 37139131 · DOI 10.3389/fcvm.2023.1084051

Verify or expand the search:

Other trials of Holter ECG

Trials testing the same drug.

NCT05896592 — Comparison of the Efficacy and Safety of Cardioneuroablation to Permanent Pacing in Patients With an Implanted Pacemaker · NA · recruiting
NCT04717843 — Identification of New Markers of Atrial Myopathy in Patients With Embolic Stroke of Undetermined Source (ESUS) From MRI · NA · unknown
NCT04003883 — ST-T Segment Changes in Emergency Physicians While on Duty · completed
NCT04129905 — Assessment of the Relations Between Endothelial and Venous Dysfunctions and Left Ventricular Obstruction in Genetic Hype · NA · completed
NCT04679987 — Incidence of Paroxysmal Atrial Fibrillation (AF) in Patients With Acute Ischemic Stroke or Transient Ischemic Attacks (T · completed

Other recruiting trials for Pulmonary Hypertension

Currently open trials in the same condition.

NCT07179380 — Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension · Phase 3 · recruiting
NCT07073820 — A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P · Phase 2 · recruiting
NCT06351345 — 129 Xenon Imaging in Patients Treated With Sotatercept · Phase 2 · recruiting
NCT07187206 — Safety and Efficacy of FETO in CDH Phase III · Phase 3 · recruiting
NCT07206173 — Londrina Activities of Daily Living Protocol in Pulmonary Hypertension · recruiting

Other Asklepios Neurological Clinic Bad Salzhausen trials

Trials by the same sponsor.

NCT05924087 — Interventional Therapy of Tracheal Stenosis · recruiting
NCT05054556 — Galectin and Respiratory Weaning · unknown
NCT04630236 — Ultrasound Guided Positioning of Central Venous Catheters · NA · completed
NCT03082339 — Cortisone and QTc-Interval · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05496504 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asklepios Neurological Clinic Bad Salzhausen
Last refreshed: 13 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05496504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing